Status:
COMPLETED
Primary and Secondary Hemostasis in Elective Coronary Artery Bypass Graft Surgery
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Coronary Disease
Eligibility:
All Genders
18-90 years
Brief Summary
Patients undergoing elective coronary artery bypass graft surgery (CABG) are treated with platelet inhibitors to reduce myocardial infarction and mortality.However, this can increase perioperative ble...
Eligibility Criteria
Inclusion
- coronary artery bypass graft surgery with or without cardiopulmonary bypass
Exclusion
- emergency; redo cardiac surgery; combined cardiac surgery; patients with renal insufficiency; patients with acquired coagulation abnormalities
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00825981
Start Date
January 1 2009
End Date
March 1 2010
Last Update
July 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques Universitaires Saint Luc
Brussels, Brussels Capital, Belgium, 1200